Novartis leads $34 million round for Stanford spinout Annexon Bioscience

Fresh perspective on a protein that could gum up the brain and lead to Huntington's disease, Alzheimer's disease and other neurodegenerative and autoimmune disorders won a $34 million investment for a Stanford University spinout...